Landanger Camus benefits from AMP acquisition
This article was originally published in Clinica
Executive Summary
Revenues at French orthopaedic implant manufacturer Landanger Camus increased to Fr 441 million ($88 million) in fiscal 1995, up 7.3% compared with last year. The company says without the acquisition of ankle prosthesis producer AMP earlier this year (see Clinica No 652, p 1), turnover would have risen only 3.8%. Foreign sales accounted for around 27% of sales for the year.